Skip to main content
. 2020 Oct 8;289(4):523–531. doi: 10.1111/joim.13178

Table 2.

Association between markers of gut involvement and inflammasome activation over time

IL‐18 IL‐18BP IL‐1β IL‐1Ra
LBP 0.29 ** (0.11, 0.47) 0.18 (−0.07, 0.42) −0.04 (−0.37, 0.29) 0.34 * (0.02, 0.66)
CCL25 0.01 (−0.10, 0.12) −0.08 (−0.30, 0.13) 0.06 (−0.20, 0.31) 0.27 * (0.03, 0.52)
IFABP 0.07 (−0.17, 0.02) 0.02 (−0.19, 0.23) −0.01 (−0.24, 0.24) 0.13 (−0.11, 0.37)

Linear mixed model with markers of inflammasome activation as dependent, time as fixed effect, and biomarker as covariates (LBP, CCL25 or IFABP), and subject as random effect. Data are given as parameter estimates (95%CI) and

*

P < 0.05,

**

P < 0.01.

Significant values are in bold.